Intelligence · Clinical Pipeline
Vertex Pharmaceuticals (Australia) Pipeline
All ClinicalTrials.gov programs at Vertex Pharmaceuticals (Australia) — phase, modality, and trial IDs.
- Programs
- 159
Quick answer
Vertex Pharmaceuticals (Australia) has 159 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
VX-840
Vertex Pharmaceuticals (Australia) Pty.
APOL1-mediated Kidney Disease
1 trial -
VX-973
Vertex Pharmaceuticals (Australia) Pty.
Pain
2 trials -
VX-985 or matching placebo
Vertex Pharmaceuticals (Australia) Pty.
Chronic Hepatitis C
1 trial -
VX-993
Vertex Pharmaceuticals (Australia) Pty.
Pain
6 trials -
Vanzacaftor
Vertex Pharmaceuticals (Australia) Pty.
Cystic Fibrosis
1 trial -
lumacaftor 200 mg q12h + ivacaftor 250 mg q12h
Vertex Pharmaceuticals (Australia) Pty.
Hepatic Impairment
1 trial -
telaprevir (VX-950)
Vertex Pharmaceuticals (Australia) Pty.
Hepatic Insufficiency
1 trial -
telaprevir formulation A
Vertex Pharmaceuticals (Australia) Pty.
Chronic Hepatitis C
1 trial -
LUM/IVA
Vertex Pharmaceuticals (Australia) Pty.
Cystic Fibrosis
8 trials -
Suzetrigine
Vertex Pharmaceuticals (Australia) Pty.
Acute Pain
2 trials -
Suzetrigine
Vertex Pharmaceuticals (Australia) Pty.
Pain
6 trials -
Telaprevir
Vertex Pharmaceuticals (Australia) Pty.
Hepatitis C
11 trials -
suzetrigine
Vertex Pharmaceuticals (Australia) Pty.
Pain, Acute Postoperative
1 trial -
AVN944
Vertex Pharmaceuticals (Australia) Pty.
Refractory Solid Tumors
1 trial -
Standard OGTT
Vertex Pharmaceuticals (Australia) Pty.
Cystic Fibrosis
1 trial
Frequently asked questions
How many pipeline programs does Vertex Pharmaceuticals (Australia) have?
159 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs